Recruitment

Recruitment Status
Unknown status

Inclusion Criterias

Patients or their legal surrogates have signed the informed consent.
Patients or their legal surrogates have signed the informed consent.

Exclusion Criterias

Usage of real-time continuous glucose monitoring system is considered as a contraindication.
Usage of real-time continuous glucose monitoring system is considered as a contraindication.

Summary

Conditions
Hyperglycemia
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Double (Participant, Outcomes Assessor)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 65 years
Gender
Both males and females

Description

Real-time continuous glucose monitoring system has shown great accuracy and feasibility in critically ill patients. However, its impact on glucose control and outcomes has nearly unknown. Thus, Investigators designed this study to evaluate the effect of real-time continuous glucose monitoring system...

Real-time continuous glucose monitoring system has shown great accuracy and feasibility in critically ill patients. However, its impact on glucose control and outcomes has nearly unknown. Thus, Investigators designed this study to evaluate the effect of real-time continuous glucose monitoring system on glucose control and outcomes of critically ill patients.

Inclusion Criterias

Patients or their legal surrogates have signed the informed consent.
Patients or their legal surrogates have signed the informed consent.

Exclusion Criterias

Usage of real-time continuous glucose monitoring system is considered as a contraindication.
Usage of real-time continuous glucose monitoring system is considered as a contraindication.

Locations

Chengdu, Sichuan, 610000
Chengdu, Sichuan, 610000

Tracking Information

NCT #
NCT01992965
Collaborators
Not Provided
Investigators
Study Director: Yan Kang, MD West China Hospital